Collex

®

All-marine hydrogel wound dressing

Discovery

Pivotal

Pre-Clinical

Feasibility

REG212

Wound healing

HTX from salmon roe• Advanced wound dressing• Medical device

Collex® is an advanced hydrogel wound dressing containing HTX™ salmon roe extract.

Collex® is currently in the late pre-clincial stage, with demonstrated significant beneficial effects on wound healing rates.

The development of Collex® is led by Regenics, with joint support from a.o. RISE AB (Sweden) and Scantox A/S (Denmark). The project is supported by a 17.3 mill NOK grant from the EU BlueBio Cofund.

Collex® is tentatively designated as a Medical Device (USA). The company intends to market the device in the US, European and other large markets.

Collex® is an advanced wound dressing designed to aid healing of partial thickness burns and chronic wounds, including diabetic and chronic vascular ulcers. With Collex®, Regenics aims to redefine the current standards of care in wound treatment.

Collex® is constructed with all-marine ingredients, sourced from the Norwegian coast. The patch is consists of alginate from brown algae and HTX™, our proprietary salmon roe extract.

A quick summary of Collex®

An all-marine advanced wound healing device.

Natural ingredients

HTX™ from salmon roe

Indication

Stage

Burns and chronic wounds

Late pre-clinical

Fourth most common type of trauma globally
Often painful and slow to heal
May cause significant scarring, disfigurement and disability

Facts on burn injuries

Combines qualities of many current standard-of-care products
Contains HTX™ to facilitate the unique healing properties of salmon roe
Faster wound closure with less complications
Provides beneficial, moist wound healing environment

Potential advantages of Collex®

Vernex